Company Filing History:
Years Active: 1990-1993
Title: Eileen Skaletsky: Innovator in Monoclonal Antibody Development
Introduction
Eileen Skaletsky is a prominent inventor based in San Diego, California. She has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. With a total of two patents to her name, her work has advanced diagnostic methods for feline diseases.
Latest Patents
One of Eileen's latest patents is the "Feline infectious peritonitis virus test utilizing monoclonal idiotypic." This invention provides novel hybridoma cell lines that produce a monoclonal idiotypic antibody designated 1030.2.3.1. This antibody binds to an antigenic determinant present on FIPV but absent on FeCV. Additionally, she has developed monoclonal anti-idiotypic antibodies designated 2814.6 and 2848.6 that mimic epitopes of the FIPV specific determinant. The patent also describes assay procedures and kits for distinguishing between FIPV and FeCV.
Another significant patent is the "Fast track method for producing monoclonal bi-specific immunoglobulins." This accelerated method involves a three-cell fusion procedure that simultaneously fuses a myeloma cell with two B lymphocytes, each expressing antibodies with different antigenic specificities. This innovation streamlines the production of bi-specific immunoglobulins, enhancing research and therapeutic applications.
Career Highlights
Eileen Skaletsky has been instrumental in her role at Synbiotics Corporation, where she has applied her expertise in immunology to develop innovative solutions. Her work has not only contributed to scientific advancements but has also had a positive impact on veterinary medicine.
Collaborations
Eileen has collaborated with notable colleagues, including Curtis N. Sharon and Elizabeth A. Oseid. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Eileen Skaletsky's contributions to the field of immunology through her patents and work at Synbiotics Corporation highlight her role as a leading inventor. Her innovative approaches to monoclonal antibody development continue to influence the landscape of veterinary diagnostics.